Business● Low49m ago · Nov 10, 2026, 10:02 AM
Senseonics targets $68M-$70M 2026 revenue as Freedom CGM human testing begins
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Senseonics has set a revenue target for 2026 as human testing for its Freedom Continuous Glucose Monitor (CGM) commences. This indicates the company's financial projections and progress in product development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business19m agoInflation report to provide 1st snapshot of prices since midterm electionsABC NewsBusiness21m agoSummit Midstream GAAP EPS of $0.58 beats by $0.46, revenue of $183M beats by $24.4MSeeking Alpha TechBusiness22m agoSecuritize to buy River Credit LabsSeeking Alpha TechBusiness25m agoArriVent BioPharma GAAP EPS of -$0.81Seeking Alpha Tech